XT
QTTB icon

XTX Topco’s Q32 Bio QTTB Stock Holding History

XTX Topco’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-20,353
Closed -$67.6K – 4493
2025
Q4 		$67.6K Buy
+20,353
New +$57.5K ﹤0.01% 2752
2024
Q1 		– Sell
-3,059
Closed -$33.5K – 2412
2023
Q4 		$33.5K Buy
3,059
+1,882
+160% +$27.5K 0.01% 1295
2023
Q3 		$24.8K Buy
+1,177
New +$24K ﹤0.01% 1352
2022
Q1 		– Sell
-1,456
Closed -$95K – 999
2021
Q4 		$95K Buy
1,456
+890
+157% +$86.4K 0.05% 475
2021
Q3 		$80K Buy
+566
New +$72.1K 0.03% 579

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

XTX Topco's QTTB Position: Q1 2026 in Review

XTX Topco sold out of Q32 Bio (QTTB) in Q1 2026, closing a stake of 20,353 shares — an estimated $67.6K sold.

XTX Topco first reported a position in QTTB in Q3 2021 and held it in 5 quarters. The position peaked at $95K in Q4 2021. 54 funds tracked by Wall St. Rank hold QTTB as of Q1 2026.

  • XTX Topco reported no remaining Q32 Bio position as of Q1 2026 after selling out during the quarter.
  • XTX Topco sold 20,353 Q32 Bio shares in Q1 2026, an estimated $67.6K.
  • XTX Topco first reported a position in Q32 Bio in Q3 2021 and held it in 5 quarters.
  • XTX Topco's Q32 Bio position peaked at $95K in Q4 2021.
  • 54 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.